Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Antinuclear antibodies in patients with chronic fatigue syndrome].

Nishikai M.

Nihon Rinsho. 2007 Jun;65(6):1067-70. Review. Japanese.

PMID:
17561698
2.

Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders.

Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K.

Rheumatology (Oxford). 2001 Jul;40(7):806-10.

PMID:
11477286
3.

Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Skowera A, Stewart E, Davis ET, Cleare AJ, Unwin C, Hull L, Ismail K, Hossain G, Wessely SC, Peakman M.

Clin Exp Immunol. 2002 Aug;129(2):354-8.

4.

Antinuclear antibodies in children with chronic nonspecific complaints.

Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, Fukunaga Y, Yamamoto M.

Autoimmunity. 1997;25(4):243-50.

PMID:
9344332
5.

Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.

Kerr JR, Bracewell J, Laing I, Mattey DL, Bernstein RM, Bruce IN, Tyrrell DA.

J Rheumatol. 2002 Mar;29(3):595-602.

PMID:
11911112
6.

Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.

Marin GG, Cardiel MH, Cornejo H, Viveros ME.

J Clin Rheumatol. 2009 Oct;15(7):325-9. doi: 10.1097/RHU.0b013e3181bb971b.

PMID:
20009966
7.
9.

Clinical and serological heterogeneity in patients with anticentromere antibodies.

Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.

J Rheumatol. 2005 Aug;32(8):1488-94.

PMID:
16078324
10.
11.

Relevance of complement fixing antinuclear antibodies.

Fang YV, Cyran SJ, Albini B, Rostami R, Binder WL, Beutner EH.

Int J Dermatol. 1999 Feb;38(2):96-100.

PMID:
10192156
12.

High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome.

von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM.

Arthritis Rheum. 1997 Feb;40(2):295-305.

PMID:
9041942
13.
14.

Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.

Pradhan VD, Patwardhan MM, Ghosh K.

Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):145-9. doi: 10.4103/0378-6323.60558.

15.

Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.

Aaron LA, Burke MM, Buchwald D.

Arch Intern Med. 2000 Jan 24;160(2):221-7.

PMID:
10647761
17.

The clinical significance of antinuclear antibodies in connective tissue disease.

Pahor A, Krajnc I, Gorenjak M, Holc I.

Wien Klin Wochenschr. 1998 May 8;110(9):338-41.

PMID:
9629626
18.

Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome.

Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi KI, Takano T, Kanakura Y, Amino N.

Int J Mol Med. 2003 Aug;12(2):225-30.

PMID:
12851722
19.

Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?

Ortega-Hernandez OD, Shoenfeld Y.

Ann N Y Acad Sci. 2009 Sep;1173:600-9. doi: 10.1111/j.1749-6632.2009.04799.x. Review.

PMID:
19758205
20.

[Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].

Bai L, Lu HY, Feng ZR, Yu M, Li WG, Gong WB, Zhao NE, Xu XY.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Aug;23(4):278-81. Chinese.

PMID:
20108773

Supplemental Content

Support Center